blujepa
Generic: gepotidacin
Labeler: glaxosmithkline llcDrug Facts
Product Profile
Brand Name
blujepa
Generic Name
gepotidacin
Labeler
glaxosmithkline llc
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
gepotidacin mesylate 750 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0173-0922
Product ID
0173-0922_1cb00eb0-9123-4532-b49e-55b9265daf9e
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA218230
Listing Expiration
2027-12-31
Marketing Start
2025-03-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
01730922
Hyphenated Format
0173-0922
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
blujepa (source: ndc)
Generic Name
gepotidacin (source: ndc)
Application Number
NDA218230 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 750 mg/1
Packaging
- 8 TABLET, FILM COATED in 1 BOTTLE (0173-0922-38)
- 20 TABLET, FILM COATED in 1 BOTTLE (0173-0922-45)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1cb00eb0-9123-4532-b49e-55b9265daf9e", "openfda": {"upc": ["0301730922458"], "unii": ["5P7X0H2O6B"], "rxcui": ["2709218", "2709224"], "spl_set_id": ["80b57cfe-7819-4d95-a57d-014af42f118d"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "8 TABLET, FILM COATED in 1 BOTTLE (0173-0922-38)", "package_ndc": "0173-0922-38", "marketing_start_date": "20251211"}, {"sample": false, "description": "20 TABLET, FILM COATED in 1 BOTTLE (0173-0922-45)", "package_ndc": "0173-0922-45", "marketing_start_date": "20250325"}], "brand_name": "Blujepa", "product_id": "0173-0922_1cb00eb0-9123-4532-b49e-55b9265daf9e", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cholinesterase Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Topoisomerase 2 Inhibitors [MoA]", "Topoisomerase 4 Inhibitors [MoA]", "Triazaacenaphthylene Bacterial Type II Topoisomerase Inhibitor [EPC]"], "product_ndc": "0173-0922", "generic_name": "gepotidacin", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Blujepa", "active_ingredients": [{"name": "GEPOTIDACIN MESYLATE", "strength": "750 mg/1"}], "application_number": "NDA218230", "marketing_category": "NDA", "marketing_start_date": "20250325", "listing_expiration_date": "20271231"}